The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schepers, K.
Right arrow Articles by Schumacher, T. N. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schepers, K.
Right arrow Articles by Schumacher, T. N. M.
The Journal of Immunology, 2002, 169: 3191-3199.
Copyright © 2002 by The American Association of Immunologists

Differential Kinetics of Antigen-Specific CD4+ and CD8+ T Cell Responses in the Regression of Retrovirus-Induced Sarcomas1

Koen Schepers*, Mireille Toebes*, Gitte Sotthewes*, Florry A. Vyth-Dreese*, Trees A. M. Dellemijn*, Cornelis J. M. Melief{dagger}, Ferry Ossendorp{dagger} and Ton N. M. Schumacher2,*

* Department of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; and {dagger} Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands

Despite the accepted role for CD4+ T cells in immune control, little is known about the development of Ag-specific CD4+ T cell immunity upon primary infection. Here we use MHC class II tetramer technology to directly visualize the Ag-specific CD4+ T cell response upon infection of mice with Moloney murine sarcoma and leukemia virus complex (MoMSV). Significant numbers of Ag-specific CD4+ T cells are detected both in lymphoid organs and in retrovirus-induced lesions early during infection, and they express the 1B11-reactive activation-induced isoform of CD43 that was recently shown to define effector CD8+ T cell populations. Comparison of the kinetics of the MoMSV-specific CD4+ and CD8+ T cell responses reveals a pronounced shift toward CD8+ T cell immunity at the site of MoMSV infection during progression of the immune response. Consistent with an important early role of Ag-specific CD4+ T cell immunity during MoMSV infection, CD4+ T cells contribute to the generation of virus-specific CD8+ T cell immunity within the lymphoid organs and are required to promote an inflammatory environment within the virus-infected tissue.




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. J. Robertson, R. J. Messer, A. B. Carmody, R. S. Mittler, C. Burlak, and K. J. Hasenkrug
CD137 Costimulation of CD8+ T Cells Confers Resistance to Suppression by Virus-Induced Regulatory T Cells
J. Immunol., April 15, 2008; 180(8): 5267 - 5274.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. J. Robertson, C. G. Ammann, R. J. Messer, A. B. Carmody, L. Myers, U. Dittmer, S. Nair, N. Gerlach, L. H. Evans, W. A. Cafruny, et al.
Suppression of Acute Anti-Friend Virus CD8+ T-Cell Responses by Coinfection with Lactate Dehydrogenase-Elevating Virus
J. Virol., January 1, 2008; 82(1): 408 - 418.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. Zelinskyy, S. Balkow, S. Schimmer, T. Werner, M. M. Simon, and U. Dittmer
The Level of Friend Retrovirus Replication Determines the Cytolytic Pathway of CD8+ T-Cell-Mediated Pathogen Control
J. Virol., November 1, 2007; 81(21): 11881 - 11890.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. W. H. G. Kessels, K. Schepers, M. D. van den Boom, D. J. Topham, and T. N. M. Schumacher
Generation of T Cell Help through a MHC Class I-Restricted TCR
J. Immunol., July 15, 2006; 177(2): 976 - 982.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. MacLeod, M. J. Kwakkenbos, A. Crawford, S. Brown, B. Stockinger, K. Schepers, T. Schumacher, and D. Gray
CD4 memory T cells survive and proliferate but fail to differentiate in the absence of CD40
J. Exp. Med., April 17, 2006; 203(4): 897 - 906.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. J. Robertson, R. J. Messer, A. B. Carmody, and K. J. Hasenkrug
In Vitro Suppression of CD8+ T Cell Function by Friend Virus-Induced Regulatory T Cells
J. Immunol., March 15, 2006; 176(6): 3342 - 3349.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Crawford, M. MacLeod, T. Schumacher, L. Corlett, and D. Gray
Primary T Cell Expansion and Differentiation In Vivo Requires Antigen Presentation by B Cells
J. Immunol., March 15, 2006; 176(6): 3498 - 3506.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. J. Shu, S. Guo, Y. J. Kim, S. M. Shelly, A. Nijagal, P. Ray, S. S. Gambhir, C. G. Radu, and O. N. Witte
Visualization of a primary anti-tumor immune response by positron emission tomography
PNAS, November 29, 2005; 102(48): 17412 - 17417.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. Zelinskyy, S. J. Robertson, S. Schimmer, R. J. Messer, K. J. Hasenkrug, and U. Dittmer
CD8+ T-Cell Dysfunction due to Cytolytic Granule Deficiency in Persistent Friend Retrovirus Infection
J. Virol., August 15, 2005; 79(16): 10619 - 10626.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Benigni, V. S. Zimmermann, S. Hugues, S. Caserta, V. Basso, L. Rivino, E. Ingulli, L. Malherbe, N. Glaichenhaus, and A. Mondino
Phenotype and Homing of CD4 Tumor-Specific T Cells Is Modulated by Tumor Bulk
J. Immunol., July 15, 2005; 175(2): 739 - 748.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Ossendorp, N. Fu, M. Camps, F. Granucci, S. J. P. Gobin, P. J. van den Elsen, D. Schuurhuis, G. J. Adema, G. B. Lipford, T. Chiba, et al.
Differential Expression Regulation of the {alpha} and {beta} Subunits of the PA28 Proteasome Activator in Mature Dendritic Cells
J. Immunol., June 15, 2005; 174(12): 7815 - 7822.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Tanaka, S. Koido, M. Ohana, C. Liu, and J. Gong
Induction of Impaired Antitumor Immunity by Fusion of MHC Class II-Deficient Dendritic Cells with Tumor Cells
J. Immunol., February 1, 2005; 174(3): 1274 - 1280.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. He, R. J. Messer, S. Sakaguchi, G. Yang, S. J. Robertson, and K. J. Hasenkrug
Reduction of Retrovirus-Induced Immunosuppression by In Vivo Modulation of T Cells during Acute Infection
J. Virol., November 1, 2004; 78(21): 11641 - 11647.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. J. Messer, U. Dittmer, K. E. Peterson, and K. J. Hasenkrug
Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infection
PNAS, August 17, 2004; 101(33): 12260 - 12265.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
R. Arens, K. Schepers, M. A. Nolte, M. F. van Oosterwijk, R. A.W. van Lier, T. N.M. Schumacher, and M. H.J. van Oers
Tumor Rejection Induced by CD70-mediated Quantitative and Qualitative Effects on Effector CD8+ T Cell Formation
J. Exp. Med., June 7, 2004; 199(11): 1595 - 1605.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Bischof, M. Hofmann, T. N. M. Schumacher, F. A. Vyth-Dreese, R. Weissert, H. Schild, A. M. Kruisbeek, and A. Melms
Analysis of Autoreactive CD4 T Cells in Experimental Autoimmune Encephalomyelitis after Primary and Secondary Challenge Using MHC Class II Tetramers
J. Immunol., March 1, 2004; 172(5): 2878 - 2884.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. E. Ressing, D. van Leeuwen, F. A. W. Verreck, R. Gomez, B. Heemskerk, M. Toebes, M. M. Mullen, T. S. Jardetzky, R. Longnecker, M. W. Schilham, et al.
Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognition
PNAS, September 30, 2003; 100(20): 11583 - 11588.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. R. M. Olbrich, S. Schimmer, K. Heeg, K. Schepers, T. N. M. Schumacher, and U. Dittmer
Effective Postexposure Treatment of Retrovirus-Induced Disease with Immunostimulatory DNA Containing CpG Motifs
J. Virol., October 11, 2002; 76(22): 11397 - 11404.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.